|4Oct 3, 4:37 PM ET

Aldag Jorn 4

4 · Unum Therapeutics Inc. · Filed Oct 3, 2019

Insider Transaction Report

Form 4
Period: 2019-10-01
Aldag Jorn
Director
Transactions
  • Award

    Stock Option (Right to Buy)

    2019-10-01$0.88/sh+15,352$13,50115,352 total
    Exercise: $1.41Exp: 2029-10-01Common Stock (15,352 underlying)
Footnotes (2)
  • [F1]The option award was issued to the Reporting Person, who elected to take shares in lieu of cash compensation for services as a director, pursuant to the Issuer's non-employee director compensation plan. The number of options granted was determined by dividing the cash compensation otherwise payable with respect to the quarter by the Black-Scholes value of a single option calculated as of the date of the grant.
  • [F2]This option is fully vested at time of grant.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION